These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24746542)

  • 1. Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.
    Scharnagl H; Kleber ME; Genser B; Kickmaier S; Renner W; Weihrauch G; Grammer T; Rossmann C; Winkelmann BR; Boehm BO; Sattler W; März W; Malle E
    Int J Cardiol; 2014 Jun; 174(1):96-105. PubMed ID: 24746542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Zelzer S; Enko D; Pilz S; Tomaschitz A; März W; Meinitzer A
    Clin Biochem; 2017 Sep; 50(13-14):739-745. PubMed ID: 28322753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
    Heslop CL; Frohlich JJ; Hill JS
    J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
    Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
    Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease.
    Tang WH; Wu Y; Nicholls SJ; Hazen SL
    Clin Chem; 2011 Jan; 57(1):33-9. PubMed ID: 21059827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long- and short-term association of low-grade systemic inflammation with cardiovascular mortality in the LURIC study.
    Kälsch AI; Scharnagl H; Kleber ME; Windpassinger C; Sattler W; Leipe J; Krämer BK; März W; Malle E
    Clin Res Cardiol; 2020 Mar; 109(3):358-373. PubMed ID: 31263995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortality.
    Woitas RP; Scharnagl H; Kleber ME; Delgado GE; Grammer TB; Pichler M; Krämer BK; März W; Stojakovic T
    PLoS One; 2017; 12(2):e0171574. PubMed ID: 28207778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.
    Kimak E; Zięba B; Duma D; Solski J
    Lipids Health Dis; 2018 Apr; 17(1):71. PubMed ID: 29618370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).
    Meinitzer A; Seelhorst U; Wellnitz B; Halwachs-Baumann G; Boehm BO; Winkelmann BR; März W
    Clin Chem; 2007 Feb; 53(2):273-83. PubMed ID: 17185364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
    Ritsch A; Scharnagl H; Eller P; Tancevski I; Duwensee K; Demetz E; Sandhofer A; Boehm BO; Winkelmann BR; Patsch JR; März W
    Circulation; 2010 Jan; 121(3):366-74. PubMed ID: 20065167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
    Ritsch A; Duerr A; Kahler P; Hunjadi M; Stojakovic T; Silbernagel G; Scharnagl H; Kleber ME; März W
    Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33233452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events.
    Wong ND; Gransar H; Narula J; Shaw L; Moon JH; Miranda-Peats R; Rozanski A; Hayes SW; Thomson LE; Friedman JD; Berman DS
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1093-9. PubMed ID: 19761988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
    Meuwese MC; Stroes ES; Hazen SL; van Miert JN; Kuivenhoven JA; Schaub RG; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
    J Am Coll Cardiol; 2007 Jul; 50(2):159-65. PubMed ID: 17616301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum myeloperoxidase and mortality in maintenance hemodialysis patients.
    Kalantar-Zadeh K; Brennan ML; Hazen SL
    Am J Kidney Dis; 2006 Jul; 48(1):59-68. PubMed ID: 16797387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective cohort studies of beta-trace protein and mortality in haemodialysis patients and patients undergoing coronary angiography.
    Enko D; Meinitzer A; Scharnagl H; Stojakovic T; Kleber ME; Delgado GE; Zelzer S; Drechsler C; Krämer BK; Wanner C; März W; Woitas RP
    Nephrol Dial Transplant; 2018 Nov; 33(11):1984-1991. PubMed ID: 29474602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma myeloperoxidase is related to the severity of coronary artery disease.
    Düzgünçinar O; Yavuz B; Hazirolan T; Deniz A; Tokgözoğlu SL; Akata D; Demirpençe E
    Acta Cardiol; 2008 Apr; 63(2):147-52. PubMed ID: 18468192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of bone turnover markers with mortality in women referred to coronary angiography: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Lerchbaum E; Schwetz V; Pilz S; Boehm BO; März W
    Osteoporos Int; 2014 Feb; 25(2):455-65. PubMed ID: 23775420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
    Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
    Variji A; Shokri Y; Fallahpour S; Zargari M; Bagheri B; Abediankenari S; Alizadeh A; Mahrooz A
    Atherosclerosis; 2019 Jan; 280():7-13. PubMed ID: 30448568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.